TABLE 2.
Characteristics of patients with proven invasive aspergillosisa
| Patient no. | Sex/age (yr) | Neutropenia (days) | Steroidsb | No. of pos. samples/total no. of samples | Time between first pos. test and clinical suspicionc | Underlying disorder or condition(s) | Site(s) of Aspergillus isolation | Fungal infection site at autopsy |
|---|---|---|---|---|---|---|---|---|
| 1 | Fe/42 | 6 | − | 9/12 | +3 | Relapsed ALL | Sputum, BAL, autopsy specimen lung | Right lung, myocardium, thyroid gland |
| 2 | Ma/10 | 18 | + | 8/12 | −7 | Relapsed ALL, alloBMT, GVHD | Autopsy specimen lung | Lung bilateral |
| 3 | Fe/43 | 10 | + | 2/5 | −3 | Relapsed NHL | Autopsy specimen lung | Lung bilateral, myocardium, liver |
| 4 | Ma/61 | 4 | + | 1/2 | −2 | NHL | Autopsy specimen lung | Right lung upper lobe |
| 5 | Ma/41 | 19 | + | 20/20 | −3 | MDS, alloBMT, GVHD | Sputum, BAL, autopsy specimen lung | Lung bilateral |
| 6 | Ma/54 | 18 | + | 5/7 | 0 | Relapsed NHL | Sputum, BAL, autopsy specimen lung | Lung bilateral, myocardium, pericardium, stomach, thyroid gland |
| 7 | Fe/70 | 54 | − | 2/2 | −3 | HCL | Sputum | Lung bilateral, liver |
| 8 | Ma/38 | 6 | + | 5/9 | −15 | AML, alloBMT, GVHD | Sputum, BAL, autopsy specimen lung | Lung bilateral |
| 9 | Fe/16 | >82 | − | 6/10 | −12 | Relapsed AML | Autopsy specimen lung | Lung bilateral, pericardium |
| 10 | Ma/33 | 3 | + | 17/18 | −22 | NHL post-liver Tx | Autopsy specimen Pericardium | Left lung, pleura, myocardium, Pericardium, kidney, thyroid gland |
| 11 | Ma/35 | 0 | + | 11/25 | −13 | ALL, alloBMT, GVHD | Sputum, BAL | Cerebral, lung bilateral |
| 12 | Ma/2.5 | 20 | − | 9/11 | +4 | AML, alloBMT | Autopsy specimen lung | Lung bilateral |
| 13 | Ma/53 | 24 | + | 7/12 | −23 | NHL-CLL | Autopsy specimen lung | Lung bilateral |
| 14 | Ma/72 | >18 | − | 5/6 | +6 | AML | Autopsy specimen lung | Lung bilateral |
| 15 | Fe/65 | 22 | − | 3/7 | +6 | AML | BAL | Lung bilateral |
| 16 | Ma/71 | 12 | − | 2/3 | −1 | sAA | Autopsy specimen lung | Right lung and pancreas |
| 17 | Fe/13 | >40 | − | 3/11 | +2 | Relapsed AML | Sputum, BAL | Lung bilateral |
| 18 | Ma/35 | 0 | + | 14/26 | −22 | AML, alloBMT, GVHD | Sputum, BAL, autopsy specimen lung | Cerebral |
| 19 | Ma/52 | 79 | + | 2/18 | −6 | Relapsed ALL | Autopsy specimen lung | Lung bilateral |
| 20 | Ma/62 | 23 | + | 0/5 | NA | NHL-CLL | Sputum, BAL | Bronchus biopsy |
| 21 | Ma/69 | >180 | − | 0/9 | NA | HCL | Sputum, BAL, autopsy specimen | Lung bilateral, trachea |
| 22 | Ma/64 | >40 | − | 5/7 | −2 | AML | Autopsy specimen | Lung bilateral, trachea |
| 23 | Fe/67 | >60 | + | 3/3 | −8 | AML | Sputum, autopsy specimen | Left lung upper lobe |
| 24 | Ma/45 | 9 | + | 2/4 | −6 | Relapsed myeloma | Autopsy specimen lung | Lung bilateral |
| 25 | Ma/57 | 19 | − | 6/9 | +4 | Relapsed AML | Autopsy specimen lung | Lung bilateral |
| 26 | Ma/69 | 24 | − | 8/10 | −5 | Refractory AML | Autopsy specimen lung | Lung bilateral |
| 27 | Ma/53 | 0 | + | 13/13 | −6 | Relapsed NHL | Sputum, BAL, autopsy specimen lung | Lung, pleura, thyroid gland |
AML, acute myeloid leukemia; ALL, acute lymphocytic leukemia; CML, chronic myeloid leukemia; sAA, severe aplastic anemia; MDS, myelodysplastic syndrome; NHL, non-Hodgkin’s lymphoma; HCL, hairy cell leukemia; AlloBMT, allogeneic bone marrow transplantation; GVHD, graft-versus-host disease; Tx, transplantation; BAL, bronchoalveolar lavage; Ma, male; Fe, female; NA, not applicable; pos, positive.
+, present; −, absent.
Values are numbers of days elapsed between first positive test result and clinical suspicion of IA. Negative numbers indicate the number of days ELISA results were positive before clinical suspicion.